Shown: posts 1 to 6 of 6. This is the beginning of the thread.
Posted by Hugh on March 19, 2020, at 13:25:51
Sage Therapeutics announced that it will conduct three new clinical trials of SAGE-217, one for postpartum depression and two for major depressive disorder.
https://www.fiercebiotech.com/biotech/sage-to-run-3-new-studies-to-save-once-failed-depression-drug
Posted by Lamdage22 on March 19, 2020, at 13:43:14
In reply to SAGE-217 update, posted by Hugh on March 19, 2020, at 13:25:51
Thanks for posting. Are there any failed trials so far?
Posted by Lamdage22 on March 19, 2020, at 13:56:50
In reply to Re: SAGE-217 update, posted by Lamdage22 on March 19, 2020, at 13:43:14
Stupid me. Sry
Posted by SLS on March 22, 2020, at 18:09:56
In reply to Re: SAGE-217 update, posted by Lamdage22 on March 19, 2020, at 13:56:50
> Stupid me. Sry
You are far from stupid. What's stupid is designing a clinical trial of an antidepressant lasting for only 15 days. The drug didn't fail. The investigators did.
- Scott
Posted by Lamdage22 on March 23, 2020, at 0:48:57
In reply to Re: SAGE-217 update, posted by SLS on March 22, 2020, at 18:09:56
Thanks. But i shall read before i post:) Where are you right now with trials? I am not doing any med trials anymore unless I think they really found something that's different to current treatments.
I have experienced so much improvement that i don't account to meds these past two years. I shall not complain.
Posted by Lamdage22 on March 23, 2020, at 0:57:13
In reply to Re: SAGE-217 update, posted by Lamdage22 on March 23, 2020, at 0:48:57
Or maybe the meds are the foundation that make this possible. I don't know.
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD, bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.